Studies of oncogene activation and tumor suppressor gene inactivation in normal and neoplastic rodent tissue

Mutation Research - Reviews in Genetic Toxicology

Volumn 365, Issue 1-3, 1996, Pages 43-58

  Buzard, Gregory S ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

genotoxic; model; mutation; oncogene; p53; Rb; rodent; suppressor gene

Indexed keywords

CARCINOGEN; PROTEIN P53;

CANCER RISK; CARCINOGENESIS; GENE ACTIVATION; GENOTOXICITY; HUMAN; KIDNEY TUMOR; LIVER TUMOR; MODEL; MOUSE; MUTAGENESIS; MUTATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RAT; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALIA; HELICOBACTER HEPATICUS; RODENTIA;

EID: 0029855419     PISSN: 01651110     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1110(96)90011-1     Document Type: Article

References (111)

1. Asamoto M., Mann A.M., Macatee T.L., Cohen S.M. Mutations and expression of the p53 gene in rat bladder carcinomas and cell lines. Mol. Carcinogen. 9:1994a;236-244.
2. Asamoto M., Mann A.M., Macatee T.L., Cohen S.M. p53 mutation is infrequent and might not give a growth advantage in rat bladder carcinogenesis in vivo. Carcinogenesis. 15:1994b;455-458.
3. Bennett L.M., Farnham P.J., Drinkwater N.R. Strain-dependent differences in DNA synthesis and gene expression in the regenerating liver of C57BL/6J and C3H/HeJ mice. Mol. Carcinogen. 14:1995;46-52.
4. Burns P.A., Kemp C.J., Gannon J.V., Lane D.P., Bremmer R., Balmain A. Loss of heterozygosity and mutational alterations of the p53 gene in mouse skin tumors of interspecific hybrid mice. Oncogene. 6:1991;2363-2369.
5. Buzard, G.S., T. Enomoto, T. Hongyo, A.O. Perantoni, B.A. Diwan, D.E. Devor, C.D. Reed, L.F. Dove and J.M. Rice, High incidence but low allelic frequency of a point mutation in the neu oncogene in schwannomas induced transplacentally in Syrian Golden hamsters by N-nitrosoethylurea , Cancer Res., submitted.
6. Calvert R.J., Tashiro Y., Buzard G.S., Diwan B.A., Weghorst C.M. Lack of p53 point mutations in chemically-induced mouse hepatoblastomas; an end-stage, highly malignant hepatocellular tumor. Cancer Lett. 95:1995;175-180.
7. Cardiff R.D., Muller W.J. Transgenic mouse models of mammary tumorigenesis. Cancer Surv. 16:1993;97-137.
8. Cardiff R.D., Munn R.J. Comparative pathology of mammary tumorigenesis in transgenic mice. Cancer Lett. 90:1995;13-19.
9. Cha R.S., Thilly W.G., Zarbl H. N-Nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations. Proc. Natl. Acad. Sci. USA. 91:1994;3749-3753.
10. Chang K.-W., Lin S-C, Koos S., Pather K., Solt D. p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas. Carcinogenesis. 17:1996;595-600.
11. Ciotti C., Dogliotti E., Bignami M. Mutation analysis of two newly identified rat p53 pseudogenes. Mutagenesis. 10:1995;123-128.
12. Coleman W.B., Grisham J.W., Smith G.J. Morphological transformation of the C3H 10T1/2 cell line is accompanied by altered expression of the p53 tumor suppressor gene. Carcinogenesis. 15:1994;145-152.
13. Counts J.L., Goodman J.I. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell. 83:1995;13-15.
14. Cryns V.L., Alexander J.M., Klibanski A., Arnold A. The retinoblastoma gene in human pituitary tumors. J. Clin. Endocrinol. Metab. 77:1993;644-646.
15. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible spontaneous tumors. Nature (Lond.). 356:1992;215-221.
16. Donehower L.A., Harvey M., Vogel H., McArthur M.J., Montgomery C.A. Jr., Park S.H., Thompson T., Ford F.J., Bradley A. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol. Carcinogen. 14:1995;16-22.
17. Donovan J.C., Mayo J.G., Rice J.M., Ward J.M., Fox J.G. Helicobacter-associated hepatitis of mice. Lab. Anim. Sci. 43:1993;403.
18. Fakuda I., Ogawa K. Alternatively-spliced p53 mRNA in the FAA-HTC1 rat hepatoma cell line without splice site mutations. Cell Struct. Funct. 17:1992;427-432.
19. Fakuda I., Ogawa K. Detection of p53 gene mutations in rat hepatocellular carcinoma cell lines by denaturing gradient gel electrophoresis. Mol. Carcinogen. 7:1993;257-262.
20. Feinberg A.P. A developmental context for multiple genetic alterations in Wilms' tumor. J. Cell Sci. 18:1994;7-12.
21. 1 in nonhuman primates. Cancer Res. 52:1992;1044-1046.
22. Gao J., Naglich J.G., Laidlaw J., Whaley J.M., Seizinger B.R., Kley N. Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene. Cancer Res. 55:1995;743-747.
23. Garibaldi M., Manenti G., Canzian F., Falvella F.S., Pierotti M.A., Della Porta G., Binelli G., Dragani T.A. Chromosome mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res. 53:1993;209-211.
24. Gnarra J.R., Tory K., Weng Y., et al. Mutations of the VHL tumor suppressor gene in renal carcinoma. Nature Genet. 7:1994;85-90.
25. Goodrow T.R., Storer R.D., Leander K.R., Prahalada S.R., VanZwieten M.J., Bradley M.O. Murine p53 intron sequences 5-8 and their use in PCR direct sequence analysis of p53 mutations in CD-1 mouse liver and lung tumors. Mol. Carcinogen. 5:1992;9-15.
26. Gorelick N.J., Andrews J.L., Gu M., Glickman B.W. Mutational spectra in the lacI gene in skin from 7,12-dimethylbenz[a]anthracene-treated and untreated transgenic mice. Mol. Carcinogen. 14:1995;53-62.
27. Harris C.C. 1995 Deichmann Lecture-p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment. Toxicol. Lett. 82/83:1995;1-7.
28. Harrison D.J., Hooper M.L., Armstrong J.F., Clarke A.R. Effects of heterozygosity for the Rb-1 t/9neo allele in the mouse. Oncogene. 10:1995;1615-1620.
29. Harvey D.M., Levine A.J. p53 alteration is a common event in the spontaneous immortilization of primary BALB/c murine embryo fibroblasts. Gene Dev. 5:1991;2375-2385.
30. Harvey M., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A., Donehower L.A. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet. 5:1993;225-229.
31. Hegi M.E., Soderkvist P., Foley J.F., Shoonhoven R., Swenberg J.A., Kari F., Maronpot R., Anderson M.W., Wiseman R.W. Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice. Carcinogenesis. 14:1993;803-810.
32. Herman J.G., Latif F., Weng Y., Lerman M.I., Zbar B., Liu S., Samid D., Duan D.-S.R., Gnarra J.R., Linehan W.M., Baylin S.B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA. 91:1994;9700-9704.
33. Higinbotham K.G., Rice J.M., Buzard G.S., Perantoni A.O. Activation of the K-ras gene by insertion mutations in chemically induced rat renal mesenchymal tumors. Oncogene. 9:1994;2455-2459.
34. Hino O., Kobayashi E., Hiriyama Y., Kobayashi T., Kubo Y., Tsuchiya H., Kikuchi Y., Mitani H. Molecular genetic basis of renal carcinogenesis in the Eker rat model of tuberous sclerosis (Tsc2). Mol. Carcinogen. 14:1995;23-27.
35. Ho Y-S., Cheng H-T., Wang Y-J., Lin J-K. p53 Gene mutational spectra in hepatocellular carcinomas induced by 2-acetylaminofluorene and N-nitroso-2- acetylaminofluorene in rats. Mol. Carcinogen. 13:1995;182-190.
36. Hongyo T., Buzard G.S., Calvert R.J., Weghorst C.M. `Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res. 21:1993;3637-3642.
37. Hongyo T., Buzard G.S., Palli D., Weghorst C.M., Amorosi A., Galli M., Caporaso N.E., Fraumeni J.F., Rice J.M. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence. Italy, Cancer Res. 55:1995;2665-2672.
38. Hopkin K. Move over, mutations: DNA methylation may drive cancer too. J. NIH Res. 7:1995;26-28.
39. Horesovsky G., Recio L., Everitt J., Goldsworthy T., Wolf D.C., Walker C. p53 Status in spontaneous and dimethylnitrosamine-induced renal cell tumors from rats. Mol. Carcinogen. 12:1995;236-240.
40. Hu N., Gutsmann A., Herbert D.C., Bradley A., Lee W.-H., Lee E.Y.-H.P. Heterozygous Rb-1 delta2 0 / + mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene. 9:1994;1021-1027.
41. Hulla J.E. The rat genome contains a p53 pseudogene: detection of a processed pseudogene using PCR. PCR Methods Appl. 1:1992;251-254.
42. 1-induced rat hepatic nodules do not exhibit a site-specific mutation within the p53 gene. Cancer Res. 53:1993;9-11.
43. Jacks T., Fazeli A., Schmitt E.M., Bronsoon R.T., Goodell M.G., Weinberg R.A. Effects of an Rb mutation in the mouse. Nature. 359:1994;295-300.
44. Jerry D.J., Butel J.S., Donehower L.A., Paulson E.J., Cochran C., Wiseman R.W., Medina D. Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice. Mol. Carcinogen. 9:1994;175-183.
45. Kamb A., Gruis N.A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S.V., et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264:1994;436-440.
46. Kemp C.J., Donhower L.A., Bradley A., Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell. 74:1993;813-822.
47. Kikuchi Y., Kobayashi E., Nishizawa M., Hamazaki S., Okada S., Hino O. Cloning of the rat homologue of the von Hippel-Lindau tumor suppressor gene and its non-somatic mutation in rat renal cell carcinomas. Jpn. J. Cancer Res. 86:1995;905-909.
48. Kitahori Y., Naitoh H., Konishi N., Fukushima M., Ohnishi T., Hiasa Y. G → A mutation of ras genes and infrequent p53 gene mutation in rat transplantable thyroid carcinoma lines from tumors induced in vivo by N-bis(2-hydroxypropyl)nitrosamine . Cancer Lett. 100:1996;55-62.
49. Krawczak M., Smith-Sorenson B., Schmidtke J., Kakkar V.V., Cooper D.N., Hovig E. Somatic spectrum of cancer-associated single basepair substitutions in the TP53 gene is determined by endogenous mechanisms of mutation and by selection, Hum. Mutation. 5:1995;48-57.
50. Kress S., Konig J., Schweizer, Lohrke H., Bauer-Hofmann R., Schwarz M. p53 mutations are absent from carcinogen-induced mouse liver tumors but occur in cell lines established from these tumors. Mol. Carcinogen. 6:1992a;148-158.
51. Kress S., Sutter C., Strictland P.T., Muktar H., Schweizer J., Schwarz M. Carcinogen-specific mutational pattern in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res. 52:1992b;6400-6403.
52. Laird P.W., Jackson-Grusby L., Fazeli A., Dickinson S.L., Jung W.E., Li E., Weinberg R.A., Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell. 81:1995;197-205.
53. Lavigueur A., Maltby V., Mock D., Rossant J., Pawson T., Bernstein A. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol. Cell Biol. 9:1989;3982-3991.
54. 1. Mol. Carcinogen. 6:1992;159-172.
55. Lin Y., Chan S.-H. Cloning and characterization of two processed p53 pseudogenes from the rat genome. Gene. 156:1995;183-189.
56. Little M., Wainwright B. Methylation and p16: suppressing the suppressor. Nature Med. 1:1995;633-634.
57. Lozano J.C., Nakazawa H., Cros M.-P., Cabral R., Yamasaki H. G → A mutations in p53 and Ha-ras genes in esophageal papillomas induced by N-nitrosomethylbenzylamine in two strains of rats. Mol. Carcinogen. 9:1994;33-39.
58. Makino H., Ishizaka Y., Tsunjimoto A., Nakamura T., Onda M., Sugimura T., Nagao M. Rat p53 gene mutations in the primary Zymbal gland tumors induced by 2-amino-3-methyimidazo[4,5-f]quinoline , a food mutagen. Proc. Natl. Acad. Sci. USA. 89:1992;4850-4854.
59. Makino H., Ushijima T., Kakiuchi H., Onda M., Ito N., Sugimura T., Nagao M. Absence of p53 mutations in rat colon tumors induced by 2-amino-6-methyldipyrido[1,2- a:3′,2′-d]imidazole,2-amino-3-methylimidazo[4,5-f] quinoline , or 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine . Jap. J. Cancer Res. 85:1994;510-514.
60. Malkin D. Germline p53 mutations and heritable cancer. Annu. Rev. Genet. 28:1994;443-465.
61. Manam D.S., Shinder G.A., Joslyn D.J., Kraynak A.R., Hammermeister C.L., Leander K.R., Ledwith B.J., Prahalada S., van Zwieten M.J., Nichols W.W. Dose-related changes in the profile of ras mutations in chemically induced CD-1 mouse livers. Carcinogenesis. 16:1995;1113-1119.
62. Manenti G., Binelli G., Gariboldi M., Canzian F., de Gregorio L., Favella F.S., Dragani T.A., Pierotti M.A. Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. Genomics. 23:1994;118-124.
63. Manenti G., de Gregorio L., Gariboldi M., Dragani T.A., Pierotti M.A. Analysis of loss of heterozygosity in murine hepatocellular tumors. Mol. Carcinogen. 13:1995;191-200.
64. Masui T., Shirai T., Imaida K., Hirose M., Futakuchi M., Tatematsu M., Ito N. Ki-ras mutations with frequent normal allele loss versus absence of p53 mutations in rat prostate and seminal vesicle carcinomas induced with 3,2′-dimethyl-4-aminobiphenyl. Mol. Carcinogen. 13:1995;21-26.
65. Murase T., Niwa K., Morishita S., Itoh N., Mori H., Tanaka T., Tamaya T. Rare occurrence of p53 and ras gene mutations in preneophastic and neoplastic mouse endometrial lesions induce by N-methyl-N-nitrosourea and 17β-estradiol. Cancer Lett. 92:1995;223-227.
66. Nakamura T., Ushijima T., Ishizaka Y., Nagao, Arai M., Yamazaki Y., Ishikawa T. Cloning and activation of the Syrian hamster neu proto-oncogene. Gene. 140:1994a;251-255.
67. Nakamura T., Ushijima T., Ishizaka Y., Nagao M., Nemoto T., Hara M., Ishikawa T. neu proto-oncogene mutation is specific for the neurofibromas in N-nitroso-N-ethylurea-induced hamster neurofibromatosis model but not for hamster melanomas and human Schwann cell tumors. Cancer Res. 54:1994b;976-980.
68. Nakazawa H., Aguelon A.-M., Yamasaki H. Identification and quantification of a carcinogen-induced molecular initiation event in cell transformation. Oncogene. 7:1992;2295-2301.
69. Nickell-Brady C., Hahn F.F., Finch G.L., Belinsky S.A. Analysis of K-ras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors. Carcinogenesis. 15:1994;257-262.
70. Nikitin A. Yu., Ballering L.A.P., Lyons J., Rajewsky M.F. Early mutation of the neu (erbB-2) gene during ethyl-nitrosourea-induced oncogenesis in the rat Schwann cell lineage. Proc. Natl. Acad. Sci. USA. 88:1991;9939-9943.
71. Nogueira E., Cardesa A., Mohr U. Experimental models of kidney tumors. J. Cancer Res. Clin. Oncol. 119:1993;190-198.
72. Ohgaki H., Hard G.C., Hirota N., Maekawa A., Takahashi M., Kleihues P. Selective mutations of codon 204 and 213 of the p53 gene in rat tumors induced by alkylating N-nitoso compounds. Cancer Res. 52:1992;2995-2998.
73. Ohta M., Inoue H., Cotticelli M.G., Kastury K., Baffa R., Pallazzo J., Siprashvilli Z., Mori M., McCue P., Druck T., Croce C.M., Huebner K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3:8) breakpoint, is abnormal in digestive tract cancers. Cell. 84:1996;587-597.
74. Orlow I., Lacombe L., Hannon G.J., Serrano M., Pellicer I., Dalbagni G., Reuter V.E., Zhang Z.-F., Beach D., Cordon-Cardo C. Deletion of the p16 and p15 genes in human bladder tumors. J. Natl. Cancer Inst. 87:1995;1524-1529.
75. Pei L., Melmed S., Scheithauer B., Kovacs K., Benedict W.F., Prager D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (Rb) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than Rb. Cancer Res. 55:1995;1613-1616.
76. Perantoni A.O., Rice J.M., Reed C.D., Watatani M., Wenk M.L. Activated neu oncogene sequences in primary tumors of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosourea. Proc. Natl. Acad. Sci. USA. 84:1987;6317-6321.
77. Perantoni A., Turusov V.S., Buzard G.S., Rice J.M. Transforming mutations in the transmembrane domain of the neu oncogene in spontaneous rat schwannomas. Mol. Carcinogen. 9:1994;230-235.
78. Purdie C.A., Harrison D.J., Peter A., Dobbie L., White S., Howie S.E.M., Salter D.M., Bird C.C., Wyllie A.W., Hooper M.L., Clarke A.R. Tumor incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene. 9:1994;603-609.
79. Quintanilla M., Brown K., Ramsden M., Balmain A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature. 322:1986;78-80.
80. Rall D.P. Can laboratory animal carcinogenicity studies predict cancer in exposed children? Environ. Health Perspect. 103:1995;173-175.
81. Reid L.H., West A., Gioeli D.G., Phillips K.K., Kelleher K.F., Araujo D., Stanbridge E.J., Dowdy S.F., Gerhard D.S., Weissman B.E. Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms' tumor assay. Hum. Mol. Genet. 5:1996;239-247.
82. Rice J.M. Helicobacter hepaticus, a recently recognized bacterial pathogen, associated with chronic hepatitis and hepatocellular neoplasia in laboratory mice. Emerg. Infect. Dis. 1:1995;129-131.
83. Riley D.J., Lai C.-C., Chang C.-Y., Jones D., Lee E.Y.-H.P., Lee W.-H. Susceptibility to tumors induced in mice by ethylnitrosourea is independent of retinoblastoma gene dosage. Cancer Res. 54:1994;6097-6101.
84. Ruggeri B., Caamano J., Goodrow T., DiRado M., Bianchi A., Trono D., Conti C.J., Klein-Szanto A.J.P. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res. 51:1991;6615-6621.
85. Ruggeri B., DiRado M., Zhang S.Y., Baure B., Goodrow T., Klein-Szanto A.J.P. Benzo(a)pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc. Natl. Acad. Sci. USA. 90:1993;1013-1017.
86. Rumsby P.C., Davies M.J., Evans J.G. Screening for p53 mutations in C3H/He mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitone. Mol. Carcinogen. 9:1994;71-75.
87. Sasaki K., Bertrand O., Nakazawa H., Fitzgerald D.J., Miranov N., Yamasaki H. Cell-type-specific ras mutations but no microsatellite instability in chemically induced mouse skin tumors and transformed 3T3 cells. Cancer Res. 55:1995;3513-3516.
88. Sharma P.M., Bowman M., Yu B.-F., Sukumar S. A rodent model for Wilms' tumors: embryonal kidney neoplasms induced by N-nitroso-N′-methylurea . Proc. Natl. Acad. Sci. USA. 91:1994;9931-9935.
89. Shiao Y.-H., G.S. Buzard, C.M. Weghorst and J.M. Rice Improved methods for consistent detection of p53 tumor suppressor gene mutations in DNA from formalin-fixed paraffin-embedded tissue, BioTechniques, submitted.
90. Shuin T., Kondo K., Torigoe S., Kishida T., Kubota Y., Hosaka M., Nagashima Y., Kitamura H., Latif F., Zbar B., Lerman M.I., Yao M. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res. 54:1994;2852-2855.
91. Smith M.L., Chandar N., Lombardi B. Low frequency of retinoblastoma gene alterations in rat hepatocellular carcinomas. Mol. Carcinogen. 8:1993a;228-233.
92. Smith M.L., Yeleswarapu L., Scalamgna P., Locker J., Lombardi B. p53 mutations in hepatocellular carcinomas induced by a choline-devoid diet in male Fisher 344 rats. Carcinogenesis. 14:1993b;503-510.
93. Smith M.L., Yeleswarapu L., Lombardi B., Shinozuka H. Lack of mutations of the p53 tumor suppressor gene in hepatocellular carcinomas induced in rats by a peroxisome proliferator. Mol. Carcinogen. 7:1993c;89-93.
94. Sukumar S., Notario V., Martin-Zanca D., Barbacid M. Induction of mammary carcinomas in rats by nitrosomethyl urea involves malignant activation of H-ras-1 locus by single point mutations. Nature. 306:1983;658-661.
95. Swafford D.S., Nikula K.J., Mitchell C.E., Belinsky S.A. Low frequency of alterations in p53, K-ras, and mdm2 in rat lung neoplasms induced by diesel exhaust or carbon black. Carcinogenesis. 16:1995;1215-1221.
96. Tennant R. The applications of transgenic animal models in cancer assessment. Mutation Res. 334:1996;. this issue.
97. Tokussashi Y., Fukuda I., Ogawa K. Absence of p53 mutations and various frequencies of Ki-ras Exon 1 mutations in rat hepatic tumors induced by different carcinogens. Mol. Carcinogen. 10:1994;45-51.
98. Ushijima T., Kakiuchi H., Makino H., Hasegawa R., Ishizaka Y., Hirai H., Yazaki T., Ito N., Sugimura T., Nagao M. Infrequent mutation of Ha-ras and p53 in rat mammary carcinomas induced by 2-amino-1-methyl-6-phenylimidazo]4,5-b]pyridine . Mol. Carcinogen. 10:1994;38-44.
99. Vancutsen P.M., Lazarus P., Williams G.M. Frequent and specific mutations of the rat p53 gene in hepatocarcinomas induced by tamoxifen. Cancer Res. 54:1994;3864-3867.
100. Walker C., Ahn Y.-T., Everitt J., Yuan X. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus. Mol. Carcinogen. 15:1996;154-161.
101. Ward J.M., Fox J.G., Anver M.R., Haines D.C., George C.V., Gilden M.J., Tully J.G., Russell R.J., Benveniste R.E., Paster B.J., Dewhirst F.E., Donovan J.C., Anderson L.M., Rice J.M. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J. Natl. Cancer Inst. 86:1994a;1222-1227.
102. Ward J.M., Anver M.R., Haines D.C., Benveniste R.E. Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am. J. Pathol. 145:1994b;959-968.
103. Webster M.A., Muller W.J. Mammary tumorigenesis and metastasis in transgenic mice, Semin. Cancer Biol. 5:1994;69-76.
104. Weghorst C.M., Buzard G.S., Calvert R.J., Hulla J.E., Rice J.M. Cloning and sequence of a processed p53 pseudogene from rat: a potential source of false `mutations' in PCR fragments of tumor DNA. Gene. 166:1995;317-322.
105. Weghorst C.M., Dragnev K.H., Buzard G.S., Thorne K.L., Vandeborne G.F., Vincent K.A., Rice J.M. Low incidence of point mutations detected in the p53 tumor suppressor gene from chemically induced rat renal mesenchymal tumors. Cancer Res. 54:1994;215-219.
106. Will K., Wernicke G., Bergmann S., Deppert W. Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53. Nucleic Acids Res. 23:1995;4023-4028.
107. Williams B.O., Remington L., Albert D.M., Mukai S., Bronson R.T., Jacks T. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nature Genet. 7:1994;480-484.
108. Yamamoto S., Masui T., Murai T., Mori S., Oohara T., Makino S., Fukushima S., Tatematsu M. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine . Carcinogenesis. 16:1995;2363-2368.
109. Zarbl H., Sukumar S., Arthur A.V., Martin-Zanca D., Baracid M. Direct mutagenesis of H-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature. 315:1985;382-385.
110. Zhang S.-Y., Baur B., Mitsunaga S.-I., Goodrow T.L., Klein-Szanto A.J.P. Lack of concordant p53 mutations in some paired primary and metastatic mouse squamous cell carcinomas induced by chemical carcinogenesis. Mol. Carcinogen. 12:1995;77-81.
111. Zhu J., Leon S.P., Beggs A.H., Busque L., Gilliland D.G., Black P.M. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J. Clin. Endocrinol. Metab. 78:1994;922-927.